4AB:FRA
AbbVie Common Stock
€259.50
arrow_upward
+1.88%(+4.80) 1D
Nov 5, 10:00:00 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
€264.00
High
€266.50
Low
€259.50
Mkt. cap
509.50B
Avg. vol.
88.00
Volume
43.00
52-wk high
€272.30
52-wk low
€167.55
No. of employees
57K
Open
€264.00
High
€266.50
Low
€259.50
Mkt. cap
509.50B
Avg. vol.
88.00
Volume
43.00
52-wk high
€272.30
52-wk low
€167.55
No. of employees
57K
News stories
From web sources and news partners
Yahoo Finance
·
1 hour ago
2 Defensive Healthcare Stocks Hitting New 52-Week Highs: ABBV & LLY
Crain's Chicago Business
·
1 hour ago
AbbVie puts $161.7 million into expanding U.K. R&D facility
Investing.com
·
9 hours ago
AbbVie stock hits all-time high at 298.74 USD
Barchart.com
·
9 hours ago
Are Wall Street Analysts Bullish on AbbVie Stock?
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorHealth Care
IndustryBiotechnology
Websiteabbvie.com